Minoxidil vs Conventional Androgenic Alopecia Treatments
The efficacy of various doses of minoxidil, dutasteride, and finateride for the treatment of male androgenic alopecia (AGA) is evaluated.
The efficacy of various doses of minoxidil, dutasteride, and finateride for the treatment of male androgenic alopecia (AGA) is evaluated.
The occurrence of cancers in patients who had received spironolactone is evaluated.
Dermatologists renowned for their expertise in trichology provided 2 recommendations per area of trichology treatment.
Less than half of women experiencing hair loss have genetic origins as the cause; possible causes and treatments are reviewed.
The link between androgenetic alopecia (AGA) and health-related quality of life (HRQOL) and psychiatric disorders was examined.
The possible benefits of topical SULT1A1 enzyme as a booster to daily 5% minoxidil treatment for androgenetic alopecia in men is investigated.
Injectable botulinum toxin as a possible adjuvant treatment for patients with androgenetic alopecia was investigated.
The safety of LDOM for the treatment of hair loss in a large cohort of patients was described.
The efficacy and safety of intradermal injections of 0.5% minoxidil for the treatment of female androgenetic alopecia were evaluated in this novel study.
Men with severe hair loss were significantly more likely to test positive for COVID-19, finds study data.